84 Business View Magazine - May 2016
The Siegfried Group
A world leader in drug manufacturing
You can expect more from Siegfried, according to
Marianne Späne, Executive Vice President & Head of
Global Business Development of Siegfried AG. Sieg-
fried has strategically transformed itself over the past
five years to become a leading, worldwide contract
development manufacturing partner (CDMO) to the
chemical and pharmaceutical industry. Siegfried of-
fers complete, integrated expertise in both drug sub-
stance formulation and drug product manufacturing,
with a proprietary portfolio of controlled substances
and APIs for use in pain and addiction. An internal
leadership strategy known as “Transform” was put in
place five years ago to establish an attractive position
for Siegfried.
